Quarterly report pursuant to Section 13 or 15(d)

3. Research and Development Expenses

3. Research and Development Expenses
9 Months Ended
Dec. 31, 2017
Research and Development [Abstract]  
Research and Development Expenses

Our research and development costs are expensed as incurred. We incurred research and development expenses during the three and nine month periods ended December 31, 2017 and 2016, which are included in various operating expense line items in the accompanying condensed consolidated statements of operations. Our research and development expenses in those periods were as follows:


    December 31,     December 31,  
    2017     2016  
Three months ended   $ 129,207     $ 178,440  
Nine months ended   $ 462,640     $ 497,075